Summary
76 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 24% a year over the last 3 years.
- It has been profitable 6 years in a row.
What to watch
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 10.0 EUR for 1 EUR of yearly profit. Over the last five years it was 11.0 EUR on average.
Valuation in detailIs it growing?
Yes, fastRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 3.4% a year over 5 years. Over the last 3 years it grew by 20% a year. Earnings per share grew by 24% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 EUR of revenue goes
- Cost of sales 18 EUR
- Sales and administration 69 EUR
- Taxes and other 3.4 EUR
- Net profit 9.9 EUR
Net profit, industry median (Insurance - Reinsurance) 9.9 EUR
Out of every 100 EUR of revenue, 9.9 EUR is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 4.41%
- Paid out of profit
- 44%
- Raised in a row
- 4 years
You receive 24.00 € per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detail